| Date Checked | 2025-12-21 23:35:33 |
|---|---|
| Graham Number | (PB)72.44 vs (PE)53.11 |
| Over / Under Value Percentage | 78.04% vs 104.72% |
| Dividend Yield | 1.88% |
| Dividend Date | 2025-11-17 |
| Symbol | ABT |
| AssetType | Common Stock |
| Name | Abbott Laboratories |
| Description | Abbott Laboratories (ABT) is a prominent American multinational healthcare company based in Abbott Park, Illinois, with expertise across a diverse range of sectors, including medical devices, diagnostics, nutritional products, and branded generic medicines. Established in 1888, Abbott has demonstrated a strong commitment to innovation, enhancing health outcomes through cutting-edge technology and comprehensive healthcare solutions. The company's strategic decision to spin off its research-based pharmaceutical operations into AbbVie in 2013 has allowed it to focus on its core offerings while maintaining a legacy of excellence in healthcare. With a robust global presence, Abbott is well-positioned to capitalize on emerging market opportunities and address evolving healthcare needs. |
| CIK | 1800 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | MEDICAL DEVICES |
| Address | 100 ABBOTT PARK ROAD, NORTH CHICAGO, IL, UNITED STATES, 60064-6400 |
| OfficialSite | https://www.abbott.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 218253558000 |
| EBITDA | 11747000000 |
| PERatio | 15.75 |
| PEGRatio | 4.168 |
| BookValue | 29.3 |
| DividendPerShare | 2.36 |
| EPS | 7.96 |
| RevenuePerShareTTM | 25.19 |
| ProfitMargin | 0.319 |
| OperatingMarginTTM | 0.194 |
| ReturnOnAssetsTTM | 0.0679 |
| ReturnOnEquityTTM | 0.306 |
| RevenueTTM | 43842998000 |
| GrossProfitTTM | 24665999000 |
| DilutedEPSTTM | 7.96 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | 0.069 |
| AnalystTargetPrice | 144.43 |
| AnalystRatingStrongBuy | 6 |
| AnalystRatingBuy | 15 |
| AnalystRatingHold | 7 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 15.75 |
| ForwardPE | 22.08 |
| PriceToSalesRatioTTM | 4.978 |
| PriceToBookRatio | 4.276 |
| EVToRevenue | 5.09 |
| EVToEBITDA | 18.94 |
| Beta | 0.719 |
| 52WeekHigh | 139.33 |
| 52WeekLow | 109.21 |
| 50DayMovingAverage | 128.97 |
| 200DayMovingAverage | 130.96 |
| SharesOutstanding | 1738872000 |
| SharesFloat | 1728665000 |
| PercentInsiders | 0.542 |
| PercentInstitutions | 81.400 |
| ExDividendDate | 2025-10-15 |
| etoro | 1 |
| dateChecked | 2025-12-21 23:35:33 |
| fresh | 1 |